+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Venlafaxine"

Neuropathic Pain Drug Market by Product Type, Route of Administration, Distribution Channel, Indication, End User - Global Forecast to 2030 - Product Thumbnail Image

Neuropathic Pain Drug Market by Product Type, Route of Administration, Distribution Channel, Indication, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 184 Pages
  • Global
From
Obsessive-Compulsive Disorder Drugs Market by Drug Class, Distribution Channel, Drug Type, Route of Administration, End User, Patient Age Group - Global Forecast to 2030 - Product Thumbnail Image

Obsessive-Compulsive Disorder Drugs Market by Drug Class, Distribution Channel, Drug Type, Route of Administration, End User, Patient Age Group - Global Forecast to 2030

  • Report
  • May 2025
  • 198 Pages
  • Global
From
Diabetic Neuropathy Market by Drug Class, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Thumbnail Image

Diabetic Neuropathy Market by Drug Class, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 195 Pages
  • Global
From
Anxiety Drugs Market by Drug Class, Route Of Administration, Distribution Channel, Patient Type - Global Forecast to 2030 - Product Thumbnail Image

Anxiety Drugs Market by Drug Class, Route Of Administration, Distribution Channel, Patient Type - Global Forecast to 2030

  • Report
  • May 2025
  • 199 Pages
  • Global
From
Anxiolytics Market by Drug Class, Route Of Administration, Form, Distribution Channel, End User - Global Forecast to 2030 - Product Thumbnail Image

Anxiolytics Market by Drug Class, Route Of Administration, Form, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 199 Pages
  • Global
From
Obsessive-Compulsive Disorder Market Report 2025 - Product Thumbnail Image

Obsessive-Compulsive Disorder Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Episodic Ataxia Treatment Market Report 2025 - Product Thumbnail Image

Episodic Ataxia Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Antidepressants Market Report 2025 - Product Thumbnail Image

Antidepressants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Selective Serotonin Reuptake Inhibitor Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Selective Serotonin Reuptake Inhibitor Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • April 2025
  • 150 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 898 Pages
  • Global
From
Antidepressants - Global Strategic Business Report - Product Thumbnail Image

Antidepressants - Global Strategic Business Report

  • Report
  • July 2025
  • 174 Pages
  • Global
From
Treatment Resistant Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cataplexy - Pipeline Insight, 2025 - Product Thumbnail Image

Cataplexy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Fragile X Syndrome: Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Fragile X Syndrome: Opportunity Assessment and Forecast - Update

  • Report
  • February 2025
  • 60 Pages
  • Global
From
Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • May 2025
  • 250 Pages
  • Global
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Research Report on China's Venlafaxine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Venlafaxine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 117 Pages
  • Global
From
Anxiety Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Anxiety Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 129 Pages
  • Global
From
Panic Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Panic Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 139 Pages
  • Global
From
Loading Indicator

Venlafaxine is a medication used to treat depression, anxiety, and panic disorder. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) and is classified as a Central Nervous System (CNS) drug. Venlafaxine works by increasing the levels of serotonin and norepinephrine in the brain, which helps to improve mood and reduce anxiety. It is available in both immediate-release and extended-release formulations. Common side effects include nausea, headache, insomnia, and dry mouth. Venlafaxine is a widely prescribed medication and is available in generic form. It is marketed by several pharmaceutical companies, including Pfizer, GlaxoSmithKline, and Mylan. It is also available in combination with other medications, such as bupropion and olanzapine. Venlafaxine is available in both brand-name and generic forms, and is available in a variety of dosage forms, including tablets, capsules, and oral solutions. Show Less Read more